To mark World Cancer Day on 4 th February, Breast Cancer Ireland has announced it’s funding of The Orla Byrne PHD Scholarship, awarded to student Louise Watson at RCSI – a four-year study into understanding key regulatory networks in breast cancer brain metastases.
You are currently browsing: Research Updates
Highlights from the Breast Cancer Ireland Dublin Cancer Conference which took place in RCSI from 19th -21st October 2022
Triple Negative Breast Cancers (TNBCs) are characterised by high rates of metastases, relapses and chemoresistance. It is now well recognised that breast cancers are not all the same and can be divided into a number of subtypes, which need to be treated differently. When compared to other subtypes of breast cancer, TNBCs often have the […]
Researchers From the University of Chicago & The BCI Research Centre at RCSI Closing in On Metastasis of the Brain
Brain tumours in general are some of the hardest to treat cancers. Whether it is a primary tumour in the brain or whether it is a metastasis, it is very difficult to treat. Drugs that target specific signalling pathways are generally thought to be superior to cytotoxic chemotherapy, when they work, because they typically avoid […]
HER-2 is a subtype of breast cancer. It is characterised because the cancer cell expresses the HER-2 receptor – a protein, that promotes the growth of cancer cells. In about one of every five breast cancers, the cancer cells have extra copies of the gene that makes the HER-2 protein. A new clinical trial, called The Shamrock […]